Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Show all lipids with this classification Show all lipids assigned to this classification.
Show only primary classification Show only those lipids which have been assigned to this class as the primary classification.
Show only secondary classifications Show only lipids which have this functionality but are not primarily assigned to this class.

Fatty Acyls [FA]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA01160016 (2R)-2-{(1R)-1-hydroxy-12-[(1R,2S)-2-{14-[(1R,2S)-2-icosylcyclopropyl]tetradecyl}cyclopropyl]dodecyl}hexacosanoic acid (2R)-2-{(1R)-1-hydroxy-12-[(1R,2S)-2-{14-[(1R,2S)-2-icosylcyclopropyl]tetradecyl}cyclopropyl]dodecyl}hexacosanoic acid FA 78:2;O C78H152O3 1137.174148
LMFA01160016 (2R)-2-{(1R)-1-hydroxy-12-[(1R,2S)-2-{14-[(1R,2S)-2-icosylcyclopropyl]tetradecyl}cyclopropyl]dodecyl}hexacosanoic acid (2R)-2-{(1R)-1-hydroxy-12-[(1R,2S)-2-{14-[(1R,2S)-2-icosylcyclopropyl]tetradecyl}cyclopropyl]dodecyl}hexacosanoic acid FA 78:2;O C78H152O3 1137.174148
LMFA13010045 3-O-(alpha-L-arabinopyranosyl-(1->6)-beta-D-glucopyranosyl) butyl 3R-hydroxybutanoate 3-O-(alpha-L-arabinopyranosyl-(1->6)-beta-D-glucopyranosyl) butyl 3R-hydroxybutanoate C19H34O12 454.205031
LMFA08020165 Anacyclin (2E,4E)-N-isobutyltetradeca-2,4-dien-8,10-diynamide NA 18:6 C18H25NO 271.193614
LMFA08020165 Anacyclin (2E,4E)-N-isobutyltetradeca-2,4-dien-8,10-diynamide NA 18:6 C18H25NO 271.193614
LMFA08020165 Anacyclin (2E,4E)-N-isobutyltetradeca-2,4-dien-8,10-diynamide NA 18:6 C18H25NO 271.193614
LMFA03030016 Thromboxane B3 (5E)-7-{4,6-dihydroxy-2-[(1E,5E)-3-hydroxyocta-1,5-dien-1-yl]oxan-3-yl}hept-5-enoic acid FA 20:4;O4 C20H32O6 368.219891
LMFA03030016 Thromboxane B3 (5E)-7-{4,6-dihydroxy-2-[(1E,5E)-3-hydroxyocta-1,5-dien-1-yl]oxan-3-yl}hept-5-enoic acid FA 20:4;O4 C20H32O6 368.219891
LMFA03030016 Thromboxane B3 (5E)-7-{4,6-dihydroxy-2-[(1E,5E)-3-hydroxyocta-1,5-dien-1-yl]oxan-3-yl}hept-5-enoic acid FA 20:4;O4 C20H32O6 368.219891
LMFA03030016 Thromboxane B3 (5E)-7-{4,6-dihydroxy-2-[(1E,5E)-3-hydroxyocta-1,5-dien-1-yl]oxan-3-yl}hept-5-enoic acid FA 20:4;O4 C20H32O6 368.219891
LMFA08010019 Dihydrolipoamide 6,8-disulfanyloctanimidic acid C8H17NOS2 207.075155
LMFA08010019 Dihydrolipoamide 6,8-disulfanyloctanimidic acid C8H17NOS2 207.075155
LMFA05000667 icosane-1,3-diol icosane-1,3-diol FOH 20:0;O C20H42O2 314.318481
LMFA01050470 2,3-dimethylmalic acid 2-hydroxy-2,3-dimethylbutanedioic acid FA 6:1;O3 C6H10O5 162.052825
LMFA01050470 2,3-dimethylmalic acid 2-hydroxy-2,3-dimethylbutanedioic acid FA 6:1;O3 C6H10O5 162.052825
LMFA13010062 1-O-(alpha-D-galactopyranosyl)-N-tetracosanyl-2-aminononane-1,3,4-triol N-[(2S,3S,4R)-1-(alpha-D-galactopyranosyloxy)-3,4-dihydroxynonan-2-yl]tetracosanamide C39H77NO9 703.559835
LMFA05000589 13-Tetradecene-1,3-diyne-6,7-diol tetradec-13-en-1,3-diyne-6,7-diol FOH 14:5;O C14H20O2 220.146330
LMFA01030951 (E)-4-Octenoic acid (4E)-oct-4-enoic acid FA 8:1 C8H14O2 142.099380
LMFA03130147 (5R,8S,11R)-d6-9-IsoF[9S,12R] (5R,8S,E)-5,8-dihydroxy-8-((2S,4R,5R)-4-hydroxy-5-((Z)-oct-2-en-1-yl)tetrahydrofuran-2-yl)oct-6-enoic acid FA 20:3;O4 C20H34O6 370.235541
LMFA07070067 Heptadecanoyl carnitine 3-(heptadecanoyloxy)-4-(trimethylazaniumyl)butanoate CAR 17:0 C24H47NO4 413.350510
LMFA07070072 Hydroxyhexanoycarnitine (3S)-3-[(3-hydroxyhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 6:0;O C13H25NO5 275.173274
LMFA07070072 Hydroxyhexanoycarnitine (3S)-3-[(3-hydroxyhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 6:0;O C13H25NO5 275.173274
LMFA07050250 3-ketopalmitoyl-CoA 3-oxohexadecanoyl-CoA CoA 16:1;O C37H64N7O18P3S 1019.324140
LMFA07050250 3-ketopalmitoyl-CoA 3-oxohexadecanoyl-CoA CoA 16:1;O C37H64N7O18P3S 1019.324140
LMFA07050250 3-ketopalmitoyl-CoA 3-oxohexadecanoyl-CoA CoA 16:1;O C37H64N7O18P3S 1019.324140
LMFA07050250 3-ketopalmitoyl-CoA 3-oxohexadecanoyl-CoA CoA 16:1;O C37H64N7O18P3S 1019.324140
LMFA07050250 3-ketopalmitoyl-CoA 3-oxohexadecanoyl-CoA CoA 16:1;O C37H64N7O18P3S 1019.324140
LMFA07050250 3-ketopalmitoyl-CoA 3-oxohexadecanoyl-CoA CoA 16:1;O C37H64N7O18P3S 1019.324140
LMFA07050250 3-ketopalmitoyl-CoA 3-oxohexadecanoyl-CoA CoA 16:1;O C37H64N7O18P3S 1019.324140
LMFA07050287 anthraniloyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-4-{[3-({2-[(2-aminobenzoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} C28H41N8O17P3S 886.152323
LMFA07050287 anthraniloyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-4-{[3-({2-[(2-aminobenzoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} C28H41N8O17P3S 886.152323
LMFA07050287 anthraniloyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-4-{[3-({2-[(2-aminobenzoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} C28H41N8O17P3S 886.152323
LMFA07050287 anthraniloyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-4-{[3-({2-[(2-aminobenzoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} C28H41N8O17P3S 886.152323
LMFA07050287 anthraniloyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-4-{[3-({2-[(2-aminobenzoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} C28H41N8O17P3S 886.152323
LMFA07050287 anthraniloyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-4-{[3-({2-[(2-aminobenzoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} C28H41N8O17P3S 886.152323
LMFA07070090 O-dodecanoylcarnitine 3-(dodecanoyloxy)-4-(trimethylazaniumyl)butanoate CAR 12:0 C19H37NO4 343.272259
LMFA07050157 (S)-3-hydroxyisobutyryl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(2S)-3-hydroxy-2-methylpropanoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 4:0;O C25H42N7O18P3S 853.151989
LMFA07050157 (S)-3-hydroxyisobutyryl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(2S)-3-hydroxy-2-methylpropanoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 4:0;O C25H42N7O18P3S 853.151989
LMFA07050157 (S)-3-hydroxyisobutyryl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(2S)-3-hydroxy-2-methylpropanoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 4:0;O C25H42N7O18P3S 853.151989
LMFA07050157 (S)-3-hydroxyisobutyryl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(2S)-3-hydroxy-2-methylpropanoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 4:0;O C25H42N7O18P3S 853.151989
LMFA07050157 (S)-3-hydroxyisobutyryl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(2S)-3-hydroxy-2-methylpropanoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 4:0;O C25H42N7O18P3S 853.151989
LMFA07050157 (S)-3-hydroxyisobutyryl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(2S)-3-hydroxy-2-methylpropanoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 4:0;O C25H42N7O18P3S 853.151989
LMFA01140053 11-(2-cyclopenten-1-yl)-4Z-Undecenoic acid 11-(2-cyclopenten-1-yl)-4Z-Undecenoic acid FA 16:3 C16H26O2 250.193280
LMFA01140053 11-(2-cyclopenten-1-yl)-4Z-Undecenoic acid 11-(2-cyclopenten-1-yl)-4Z-Undecenoic acid FA 16:3 C16H26O2 250.193280
LMFA07010766 4,6-Decadiyn-1-ol isovalerate deca-4,6-diyn-1-yl 3-methylbutanoate WE 15:4 C15H22O2 234.161980
LMFA07010766 4,6-Decadiyn-1-ol isovalerate deca-4,6-diyn-1-yl 3-methylbutanoate WE 15:4 C15H22O2 234.161980
LMFA07011643 2-oxo-2-phenylethyl-12S-hydroxyhexadecanoate WE 24:5;O2 C24H38O4 390.277011
LMFA08020449 Inconspicamide N-(1,3-dihydroxypropan-2-yl)-11-methyloctadecanamide NA 22:0;O2 C22H45NO3 371.339944
LMFA01030224 2Z-dodecenoic acid 2Z-dodecenoic acid FA 12:1 C12H22O2 198.161980
LMFA07010724 2-Methylbutyl 3-methyl-2-butenoate 2-methylbutyl 3-methylbut-2-enoate WE 10:1 C10H18O2 170.130680